EUDA Health
Yahoo Finance • last month
EUDA Health price target lowered to $2.75 from $6 at Greenridge
Greenridge analyst William Gregozeski lowered the firm’s price target on EUDA Health (EUDA) to $2.75 from $6 and keeps a Buy rating on the shares. The firm updated its model for a reduction of Helixe bottles sold in 2026, decreasing to 50,... Full story
Yahoo Finance • 3 months ago
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital
SINGAPORE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company,” a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced the l... Full story
Yahoo Finance • 4 months ago
EUDA Health to Launch EUDA Helixé 2.0 in January 2026
SINGAPORE, Dec. 29, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that... Full story
Yahoo Finance • 4 months ago
EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem
SINGAPORE, Dec. 22, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a str... Full story
Yahoo Finance • 4 months ago
Healthcare Names Post Strong After-Hours Moves: KYMR, OCUL, POAI Among Top Gainers
(RTTNews) - Several healthcare and biotech names posted notable gains in Friday's after-hours trading session, with momentum driven by clinical updates, recent announcements, and technical rebounds. Kymera Therapeutics Inc. (KYMR) surged... Full story
Yahoo Finance • 4 months ago
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
SINGAPORE, Dec. 05, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or “the Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced th... Full story
Yahoo Finance • 7 months ago
EUDA Signs Letter of Intent to Potentially Acquire GO POSB
SINGAPORE, Sept. 10, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced t... Full story
Yahoo Finance • 8 months ago
EUDA Health signs letter of intent to acquire Chemokine
* EUDA_ _Health (NASDAQ:EUDA [https://seekingalpha.com/symbol/EUDA]) announced on Thursday that it has signed a letter of intent to potentially acquire Chemokine. * EUDA will carry out due diligence on Chemokine, subject to confidentia... Full story
Yahoo Finance • 3 years ago
EUDA Health Holdings Limited Enters into Letter of Intent for Proposed Merger with TheoremRx Inc.
SINGAPORE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patie... Full story
Yahoo Finance • 3 years ago
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements
Singapore, Sept. 22, 2023 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on Augu... Full story
